ViViRA new round from Ship2B Ventures and BonVenture with Metrix Partners’ Support

Vivira Round (DiGA) Advised by Metrix Partners

Vivira, a German digital health startup, raised funds from Ship2B Ventures and BonVenture. Metrix Partners advised on the transaction. This investment will boost Vivira’s growth and expand its reach in the German DiGA (Digital Health Application) market. Germany has one of the most advanced digital healthcare ecosystems in Europe.

Vivira offers a digital therapy platform that helps users manage musculoskeletal conditions, like back pain, with clinically validated exercises. It is a key player in the German DiGA market. The company has earned approval from the Federal Institute for Drugs and Medical Devices (BfArM), making its app reimbursable by statutory health insurance.

About the DiGA Market

The DiGA market was established by the 2019 Digital Healthcare Act (Digitale-Versorgung-Gesetz). It allows patients to use prescribed digital health apps covered by health insurers. This regulatory framework encourages innovation in digital therapeutics. It also improves access to digital healthcare solutions like Vivira’s, benefiting millions of patients.

The Transaction

Ship2B Ventures and BonVenture, known for socially impactful investments, saw Vivira’s potential to improve patient care. Their investment will help Vivira scale its operations, enhance its product, and reach more patients. These investors focus on purpose-driven startups, and Vivira’s commitment to better patient outcomes aligns perfectly with their mission.

Our Role

Metrix Partners played a key role in the investment process. We provided Ship2B Ventures and BonVenture with financial and business due diligence. Our analysis reviewed Vivira’s financial health, market potential, and business model. This helped the investors make informed decisions and ensured Vivira’s strong position for growth in the DiGA market.

With this funding, Vivira is set to expand in the digital health sector and continue transforming patient care. We are proud to have supported this collaboration and look forward to Vivira’s future impact.

Full news here